Teligent - 10 Year Stock Split History | TLGT

Stock split history for Teligent since 2011. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $44.899B 17.67
BridgeBio Pharma (BBIO) United States $13.352B 0.00
Dr Reddy's Laboratories (RDY) India $9.749B 24.85
Aspen Pharmacare (APNHY) South Africa $4.248B 0.00
Supernus Pharmaceuticals (SUPN) United States $2.409B 20.18
Bausch Health Cos (BHC) Canada $2.129B 1.33
Personalis (PSNL) United States $1.687B 0.00
Taysha Gene Therapies (TSHA) United States $1.652B 0.00
Amphastar Pharmaceuticals (AMPH) United States $1.019B 9.58
Assembly Biosciences (ASMB) United States $0.519B 24.98
Sol-Gel Technologies (SLGL) Israel $0.178B 0.00
Metagenomi Therapeutics (MGX) United States $0.043B 0.00
Evoke Pharma (EVOK) United States $0.019B 0.00